Correction to: Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results (Pituitary, (2021), 24, 6, (943-953), 10.1007/s11102-021-01163-2)

Artak Labadzhyan; L. B. Nachtigall; M. Fleseriu; M. B. Gordon; M. Molitch; L. Kennedy; S. L. Samson; Y. Greenman; N. Biermasz; M. Bolanowski; A. Haviv; W. Ludlam; G. Patou; C. J. Strasburger

doi:10.1007/s11102-021-01177-w

Correction to: Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results (Pituitary, (2021), 24, 6, (943-953), 10.1007/s11102-021-01163-2)

Artak Labadzhyan^*, L. B. Nachtigall, M. Fleseriu, M. B. Gordon, M. Molitch, L. Kennedy, S. L. Samson, Y. Greenman, N. Biermasz, M. Bolanowski, A. Haviv, W. Ludlam, G. Patou, C. J. Strasburger

^*Corresponding author for this work

Medicine, Endocrinology Division

Research output: Contribution to journal › Comment/debate › peer-review

4 Scopus citations

Abstract

The article ‘Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results’, written by Artak Labadzhyan, L B Nachtigall, M Fleseriu, M B Gordon, M Molitch, L Kennedy, S L Samson, Y Greenman, N Biermasz, M Bolanowski, A Haviv, W Ludlam, G Patou and C J Strasburger was originally published electronically on the publisher’s internet portal on 25 June 2021 without open access.

Original language	English (US)
Pages (from-to)	954
Number of pages	1
Journal	Pituitary
Volume	24
Issue number	6
DOIs	https://doi.org/10.1007/s11102-021-01177-w
State	Published - Dec 2021

ASJC Scopus subject areas

Endocrinology, Diabetes and Metabolism
Endocrinology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s11102-021-01177-w

Cite this

Labadzhyan, A., Nachtigall, L. B., Fleseriu, M., Gordon, M. B., Molitch, M., Kennedy, L., Samson, S. L., Greenman, Y., Biermasz, N., Bolanowski, M., Haviv, A., Ludlam, W., Patou, G., & Strasburger, C. J. (2021). Correction to: Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results (Pituitary, (2021), 24, 6, (943-953), 10.1007/s11102-021-01163-2). Pituitary, 24(6), 954. https://doi.org/10.1007/s11102-021-01177-w

@article{8e1ef1d16a5e40769e3a95af8ff78d13,

title = "Correction to: Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results (Pituitary, (2021), 24, 6, (943-953), 10.1007/s11102-021-01163-2)",

abstract = "The article {\textquoteleft}Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results{\textquoteright}, written by Artak Labadzhyan, L B Nachtigall, M Fleseriu, M B Gordon, M Molitch, L Kennedy, S L Samson, Y Greenman, N Biermasz, M Bolanowski, A Haviv, W Ludlam, G Patou and C J Strasburger was originally published electronically on the publisher{\textquoteright}s internet portal on 25 June 2021 without open access.",

author = "Artak Labadzhyan and Nachtigall, {L. B.} and M. Fleseriu and Gordon, {M. B.} and M. Molitch and L. Kennedy and Samson, {S. L.} and Y. Greenman and N. Biermasz and M. Bolanowski and A. Haviv and W. Ludlam and G. Patou and Strasburger, {C. J.}",

note = "Publisher Copyright: {\textcopyright} 2021, The Author(s).",

year = "2021",

month = dec,

doi = "10.1007/s11102-021-01177-w",

language = "English (US)",

volume = "24",

pages = "954",

journal = "Pituitary",

issn = "1386-341X",

publisher = "Springer",

number = "6",

}

Labadzhyan, A, Nachtigall, LB, Fleseriu, M, Gordon, MB, Molitch, M, Kennedy, L, Samson, SL, Greenman, Y, Biermasz, N, Bolanowski, M, Haviv, A, Ludlam, W, Patou, G & Strasburger, CJ 2021, 'Correction to: Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results (Pituitary, (2021), 24, 6, (943-953), 10.1007/s11102-021-01163-2)', Pituitary, vol. 24, no. 6, pp. 954. https://doi.org/10.1007/s11102-021-01177-w

TY - JOUR

T1 - Correction to

T2 - Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results (Pituitary, (2021), 24, 6, (943-953), 10.1007/s11102-021-01163-2)

AU - Labadzhyan, Artak

AU - Nachtigall, L. B.

AU - Fleseriu, M.

AU - Gordon, M. B.

AU - Molitch, M.

AU - Kennedy, L.

AU - Samson, S. L.

AU - Greenman, Y.

AU - Biermasz, N.

AU - Bolanowski, M.

AU - Haviv, A.

AU - Ludlam, W.

AU - Patou, G.

AU - Strasburger, C. J.

PY - 2021/12

Y1 - 2021/12

N2 - The article ‘Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results’, written by Artak Labadzhyan, L B Nachtigall, M Fleseriu, M B Gordon, M Molitch, L Kennedy, S L Samson, Y Greenman, N Biermasz, M Bolanowski, A Haviv, W Ludlam, G Patou and C J Strasburger was originally published electronically on the publisher’s internet portal on 25 June 2021 without open access.

AB - The article ‘Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results’, written by Artak Labadzhyan, L B Nachtigall, M Fleseriu, M B Gordon, M Molitch, L Kennedy, S L Samson, Y Greenman, N Biermasz, M Bolanowski, A Haviv, W Ludlam, G Patou and C J Strasburger was originally published electronically on the publisher’s internet portal on 25 June 2021 without open access.

UR - http://www.scopus.com/inward/record.url?scp=85113168886&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85113168886&partnerID=8YFLogxK

U2 - 10.1007/s11102-021-01177-w

DO - 10.1007/s11102-021-01177-w

M3 - Comment/debate

C2 - 34347226

AN - SCOPUS:85113168886

SN - 1386-341X

VL - 24

SP - 954

JO - Pituitary

JF - Pituitary

IS - 6

ER -

Correction to: Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results (Pituitary, (2021), 24, 6, (943-953), 10.1007/s11102-021-01163-2)

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this